article graphic

News & insights

Filter by:

Filters

Synapse - AI in Life Sciences

Data privacy in AI due diligence

AI has become an integral part of business operations across various industries. Its deployment demands careful legal and strategic considerations. Before integrating AI systems in a company’s workflows, thorough diligence should be conducted.

6 March 2025
Quick read

by Dr. Carolin Monsees, CIPP/E

7 of 10 Insights

Click here to find out more
Synapse - AI in Life Sciences

The regulation of clinical trials in which AI is deployed

While the AI Act is not applicable to certain research uses of AI, these exemptions do not apply to the use of AI in clinical trials, where a myriad of regulation and guidance has potential application.

6 March 2025
Quick read

by Alison Dennis

2 of 10 Insights

Click here to find out more
Glass.Mapper.Sc.Fields.Image?.Alt
Financial services regulatory

FinTech Matters - March 2025

6 March 2025
In-depth analysis

by Martin Dowdall and Daniel Hirschfield

Click here to find out more
Glass.Mapper.Sc.Fields.Image?.Alt
Disputes & investigations

Fishing for evidence: when courts say no to cross-border requests

6 March 2025
Briefing

by multiple authors

Click here to find out more
Glass.Mapper.Sc.Fields.Image?.Alt
Patents & innovation

The UPC: a new rocket docket for life sciences patent litigation

6 March 2025

by Dr Paul England

Click here to find out more
Synapse - AI in Life Sciences

Data privacy in AI pre-contractual due diligence

AI is transforming healthcare and life sciences, by enabling innovations in diagnostics, treatment personalisation, and operational efficiency. This article explores essential considerations for data privacy in pre-contractual AI due diligence, focusing on legal obligations, risk mitigation strategies, and ethical concerns.

6 March 2025

by Christopher Bakier

8 of 10 Insights

Click here to find out more
Synapse - AI in Life Sciences

Navigating IP in AI due diligence

As AI models evolve over time, specific considerations will need to be incorporated into any due diligence. These include whether the solution is licensed-in to be licensed-out and has been pretrained/trained with third party or customer data.

6 March 2025
Quick read

by Marc Schuler

9 of 10 Insights

Click here to find out more
Glass.Mapper.Sc.Fields.Image?.Alt
Consumer & retail

Fashion and luxury market update

5 March 2025
Quick read

by Jason Rawkins and Simon Jupp

Click here to find out more
Glass.Mapper.Sc.Fields.Image?.Alt
Corporate/M&A & capital markets

Advising Lessmore on its sale to Miniclip

5 March 2025

by Richard Faichney and Robert Fenner

Click here to find out more
Call To Action Arrow Image

Events

Hear from our experts as they discuss the latest legal issues.

Browse our events
Browse our events